COVAX aims to deliver 2 billion doses of effective, approved COVID-19 vaccines by the end of 2021. Image: REUTERS/Agustin Marcarian
Explore and monitor how Vaccination is affecting economies, industries and global issues
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
License and Republishing
The views expressed in this article are those of the author alone and not the World Economic Forum.
The Agenda Weekly
A weekly update of the most important issues driving the global agenda